ID
20365
Beschrijving
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 6 (Month 18) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Trefwoorden
Versies (1)
- 21-02-17 21-02-17 -
Geüploaded op
21 februari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Trial Medication Compliance Discontinuation Dispense Visit 6 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Trial Medication Compliance Discontinuation Dispense Visit 6 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Beschrijving
Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Beschrijving
Discontinuation Of Trial Medication
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0457454
Beschrijving
If the patient permanently discontinued one or more of the trial medications since the previous visit, please record detailed information on the Permanent Termination of Trial Medication page 48. Even if the patient has stopped all trial medication he/she should be encouraged to return for all remaining visits.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0205355
Beschrijving
5. Discontinuation Of Trial Medication
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0457454
Beschrijving
Adverse Event Led to Discontinuation
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0457454
Beschrijving
Drug
Datatype
integer
Alias
- UMLS CUI [1]
- C0013227
Beschrijving
Date Stopped
Datatype
date
Alias
- UMLS CUI [1]
- C1531784
Beschrijving
Date Restarted
Datatype
date
Alias
- UMLS CUI [1]
- C3173309
Beschrijving
Trial Medication due to an Adverse Event
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1531784
Beschrijving
if Yes
Datatype
text
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Dispense Trail Medication
Alias
- UMLS CUI-1
- C0947323
Beschrijving
Preparation for next visit
Alias
- UMLS CUI-1
- C1521827
- UMLS CUI-2
- C0545082
Beschrijving
Signature
Datatype
text
Alias
- UMLS CUI [1]
- C1519316
Beschrijving
Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1519316
Similar models
Trial Medication Compliance Discontinuation Dispense Visit 6 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0013227 (UMLS CUI-2)
C0457432 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,2])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C1531784 (UMLS CUI [1,2])
C0545082 (UMLS CUI-2)
C1519316 (UMLS CUI [1,2])